Electromed, Inc.

Electromed, Inc. Q1 2027 Earnings Recap

ELMD Q1 2027 Published November 14, 2026

Get alerts when ELMD reports next quarter

Set up alerts — free

Electromed shares fell 8.2% after earnings, despite higher revenue and operating income. The likely concern is the sharp contraction in distributor and hospital revenue, which tempers the 17.6% growth in the core home-care channel; the supplied transcript provides no updated guidance to explain the market’s reaction.

Earnings Per Share Beat
$0.32 vs $0.26 est.
+25.5% surprise
Revenue Miss
18682000 vs 18850000 est.
-0.9% surprise

Market Reaction

Post-Earnings -8.17%

See ELMD alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Q1 revenue rose 10.6% year over year to $18.7 million; operating income increased 30.7% to $3.5 million.
  • Diluted EPS was $0.32, up 28% from $0.25 a year earlier.
  • Home-care revenue grew 17.6% and accounted for 94% of revenue. Distributor revenue fell 56%, while hospital revenue declined 32%.
  • Electromed ended the quarter with 63 direct home-care sales representatives and four open territories; it also renewed its contract with the largest hospital GPO in the country.
  • SmartOrder handled 48% of Q1 orders, which shipped about five days faster than fax-based orders.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit ELMD on AllInvestView.

Get the Full Picture on ELMD

Track Electromed, Inc. in your portfolio with real-time analytics, dividend tracking, and more.

View ELMD Analysis